The role of antithrombotic therapy on the patency of peripheral bypasses

Citation
Ra. Bucek et al., The role of antithrombotic therapy on the patency of peripheral bypasses, VASA, 29(3), 2000, pp. 163-167
Citations number
42
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
VASA-JOURNAL OF VASCULAR DISEASES
ISSN journal
03011526 → ACNP
Volume
29
Issue
3
Year of publication
2000
Pages
163 - 167
Database
ISI
SICI code
0301-1526(200007)29:3<163:TROATO>2.0.ZU;2-1
Abstract
peripheral bypass surgery is a well-established treatment for symptomatic a therosclerotic disease of the legs. To improve the long-term patency antith rombotic drugs and other adjuvant treatment are applied In this review we s ummarize the results of randomized studies concerning antithrombotic treatm ent for prophylaxis after peripheral bypass surgery Heparin is used routine ly intra- and perioperatively without strong data, and according to few dat a low molecular weight heparin may be superior in this situation. Aspirin h ad positive effects in placebo-controlled studies after infrainguinal PTFE- bypasses, furthermore it is recommended due to its general cardiovascular r isk reduction. Ticlopidine improved long-term patency in one randomized stu dy after venous bypass surgery. Otherwise there are some data that long-ter m oral anticoagulation may be preferable in patients after venous bypass su rgery.